DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
Assam is home to more than 1,700 species of medicinal plants
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year
The recipient is a 57-year-old woman who was suffering from severe biventricular heart failure and had undergone cardiac surgery several years ago
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
Subscribe To Our Newsletter & Stay Updated